STOCK TITAN

iCoreConnect Inc. - ICCT STOCK NEWS

Welcome to our dedicated page for iCoreConnect news (Ticker: ICCT), a resource for investors and traders seeking the latest updates and insights on iCoreConnect stock.

iCoreConnect Inc. develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Rhea-AI Summary

iCoreConnect, Inc. (OTCQB: ICCT) has received endorsement from the Pennsylvania Dental Association (PDA) for its iCoreHIPAA and iCoreExchange platforms, which support HIPAA compliance for dental practices. This endorsement is part of PDA’s Member Advantage Program, aimed at providing secure and high-quality products. CEO Robert McDermott highlighted the importance of these solutions in addressing cybersecurity threats and improving workflow efficiency. iCoreConnect has garnered over 100 endorsements from various state dental and medical associations, reflecting its commitment to enhancing practice profitability and security. The iCoreHIPAA platform offers detailed risk assessments, while iCoreExchange provides secure email solutions that exceed federal HIPAA standards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

iCoreConnect, a cloud-based software and technology company, reported impressive financial growth for 2022. Revenues surged by 60% to $8 million, up from $5 million in 2021, driven by a 20% increase in subscriber count to 30,000. The company's gross profit margin improved to 72% from 68%. CEO Robert McDermott highlighted robust growth across all products and successful launches of additional services. Key endorsements from four state associations boosted credibility, and partnerships with large enterprise clients enhanced market reach. Looking forward, iCoreConnect aims to leverage its strong foundation for continued growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its iCoreVerify automated insurance verification software by Louisiana Dental Services, Inc. (LDS), a subsidiary of the Louisiana Dental Association (LDA). This marks iCoreConnect's second endorsed product, enhancing workflow efficiency by automating the insurance verification process, saving dental practices 20-40 hours weekly. LDS President, Dr. Bill Hadlock, emphasized the software's capability to significantly reduce verification workload while improving patient care and revenue planning. iCoreConnect continues to showcase its commitment to healthcare innovation through cloud-based solutions aimed at improving profitability for dental practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

OCOEE, FL, March 7, 2023 – iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its cloud-based ePrescription software, iCoreRx, by the Nebraska Dental Association (NDA). iCoreRx, which includes an add-on for electronically prescribing controlled substances, has over 40 endorsement agreements nationwide. As Nebraska's new ePrescribing law takes effect on January 1, 2024, iCoreConnect aims to help dental practices comply while enhancing workflow and patient safety. The NDA emphasized the benefits of iCoreRx's integration capabilities and cloud-based flexibility. iCoreConnect continues to lead with innovative, compliance-focused solutions in healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its iCoreRx Electronic Prescription software by the Maryland State Dental Association (MSDA), following a previous endorsement for its iCoreVerify software in 2021. This endorsement coincides with new regulations requiring Maryland doctors to send electronic prescriptions for controlled substances starting January 1, 2023. iCoreRx enables secure prescribing from any internet-connected device and integrates with practice management software, enhancing workflow and patient safety. iCoreConnect emphasizes its commitment to improving healthcare efficiency through its comprehensive SaaS solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

iCoreConnect (OTCQB: ICCT), a SaaS company focused on healthcare workflow solutions, announced a partnership with Yankee Alliance, a large group purchasing organization with nearly 20,000 members. This collaboration marks iCoreConnect's first with a national GPO, allowing joint marketing of its products to Yankee Alliance's members. The partnership is expected to enhance workflow efficiency in medical practices through cloud-based solutions like iCoreRx ePrescribing and iCoreVerify insurance verification. The partnership aims to save time and money for healthcare providers while improving patient care quality.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary

iCoreConnect (OTCQB: ICCT), a cloud-based software company, announced the addition of Kevin McDermott from SAP and Harry Travis from The Travis Group to its Board of Directors. This strategic move coincides with the company's business combination agreement with FG Merger Corp., aiming to enhance shareholder value and expand into enterprise markets. McDermott brings 19 years of experience at SAP, while Travis has a strong background in healthcare management, having led operations at CVS Caremark. The company currently offers a suite of 15 SaaS solutions and has over 90 agreements with healthcare associations nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary

iCoreConnect, Inc. (OTCQB: ICCT) has launched iCoreVerify+, a new software and concierge service that enhances its existing iCoreVerify automated insurance verification offerings. This service addresses the labor challenges in dental practices by managing the remaining 20% of manual verification work that the automated system can't complete. By freeing up practice staff, iCoreVerify+ allows them to focus on revenue-generating activities and patient care. The company has garnered over 90 product endorsement agreements from state dental and medical associations nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

FG Merger Corp. (FGMC) announced a business combination with iCoreConnect, valuing iCoreConnect at $98 million. This merger will facilitate iCoreConnect's transition from OTC to Nasdaq under the symbol ICCT. Existing FGMC shareholders can convert their equity into preferred stock with a 12% coupon for the first two years. iCoreConnect, a SaaS provider, has seen a 65% revenue CAGR since 2018, projected to achieve $8.1 million revenue in 2022. The merger aims to leverage healthcare technology trends and significant market potential.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of three products by The PROPS Center, a subsidiary of the Connecticut State Dental Association. The endorsed products include: iCoreRx, a cloud ePrescribing software; iCoreCloud, a HIPAA-compliant encrypted backup solution; and iCoreCodeGenius, which offers rapid ICD-10 coding. The partnership aims to enhance efficiency and operational security for dental practices, with a focus on improving workflow productivity and profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of iCoreConnect (ICCT)?

The current stock price of iCoreConnect (ICCT) is $2.87 as of December 24, 2024.

What is the market cap of iCoreConnect (ICCT)?

The market cap of iCoreConnect (ICCT) is approximately 69.8M.

What does iCoreConnect Inc. specialize in?

iCoreConnect Inc. specializes in developing and marketing secure cloud-based HIPAA compliant software services.

Which markets does iCoreConnect Inc. cater to?

iCoreConnect Inc. caters to vertical markets such as legal, financial, and education fields that require secure data communication.

What are some of the software offerings by iCoreConnect Inc.?

Some of the software offerings by iCoreConnect Inc. include iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay.

How does iCoreConnect Inc. sell its software products?

iCoreConnect Inc. sells its software products under annual recurring revenue subscriptions.

What is the reporting focus of iCoreConnect Inc.?

iCoreConnect Inc. has a single reporting segment focused on the North American market.

iCoreConnect Inc.

OTC:ICCT

ICCT Rankings

ICCT Stock Data

69.81M
1.43M
33.45%
9.19%
1.02%
Health Information Services
Services-prepackaged Software
Link
United States of America
OCOEE